These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 12832744
1. Sustained response with negative serum HCV-mRNA and disappearance of antibodies after interferon-alpha therapy in a kidney transplant recipient with chronic active viral hepatitis C. Luciani G, Bossola M, Muscaritoli M, Panocchia N, Ferrante A, Nanni G, Piccioni E, Tazza L, Grillo RL, Rossi Fanelli F, Castagneto M. J Nephrol; 2003; 16(3):417-20. PubMed ID: 12832744 [Abstract] [Full Text] [Related]
7. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response. Chu CM, Sheen IS, Liaw YF. Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075 [Abstract] [Full Text] [Related]
11. Long-term follow-up after successful interferon therapy of acute hepatitis C. Wiegand J, Jäckel E, Cornberg M, Hinrichsen H, Dietrich M, Kroeger J, Fritsch WP, Kubitschke A, Aslan N, Tillmann HL, Manns MP, Wedemeyer H. Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091 [Abstract] [Full Text] [Related]
15. Types of human leukocyte antigen and decrease in HCV core antigen in serum for predicting efficacy of interferon-Alpha in patients with chronic hepatitis C: analysis by a prospective study. Muto H, Tanaka E, Matsumoto A, Yoshizawa K, Kiyosawa K, Nagano Interferon Treatment Research Group. J Gastroenterol; 2004 Jul; 39(7):674-80. PubMed ID: 15293139 [Abstract] [Full Text] [Related]
16. Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy. Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Suzuki F, Akuta N, Someya T, Hosaka T, Kobayashi M, Kumada H. J Gastroenterol; 2004 Jul; 39(5):455-60. PubMed ID: 15175944 [Abstract] [Full Text] [Related]
17. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C. Zografos TA, Liaskos C, Rigopoulou EI, Togousidis E, Makaritsis K, Germenis A, Dalekos GN. Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648 [Abstract] [Full Text] [Related]
18. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus. Uyama H, Enomoto H, Kishima Y, Yamamoto M, Yoshida K, Okuda Y, Hirotani T, Kuroda T, Ito H, Matsuda M, Terabayashi M, Noguchi S, Kawase I, Nakamura H. Hepatogastroenterology; 2003 Mar; 50(54):2112-6. PubMed ID: 14696476 [Abstract] [Full Text] [Related]
19. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy. Januszkiewicz-Lewandowska D, Wysocki J, Pernak M, Nowicka K, Zawada M, Rembowska J, Lewandowski K, Mańkowski P, Nowak J. Jpn J Infect Dis; 2007 Feb; 60(1):29-32. PubMed ID: 17314422 [Abstract] [Full Text] [Related]